SPINEWAY Inactive Instrument
SPINEWAY Stock Swiss Exchange
Equities
FR0011398874
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
||
| - EUR | - |
|
| 04-17 | Spineway: punished despite a solid first quarter | CF |
| 04-16 | Spineway SA Announces Revenue Results for the First Quarter of 2024 | CI |
| Sales 2022 | 8.53M 9.25M 12.61M | Sales 2023 | 11.36M 12.31M 16.78M | Capitalization | 499K 541K 738K |
|---|---|---|---|---|---|
| Net income 2022 | -3M -3.25M -4.43M | Net income 2023 | -6M -6.5M -8.87M | EV / Sales 2022 | - |
| Net cash position 2022 | 4.08M 4.43M 6.04M | Net Debt 2023 | 814K 882K 1.2M | EV / Sales 2023 | - |
| P/E ratio 2022 * |
-
| P/E ratio 2023 |
-
| Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 2.55% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Stéphane Le Roux
CEO | Chief Executive Officer | 63 | 05-09-27 |
| Director of Finance/CFO | - | 20-01-26 | |
Sandrine Carle
PRN | Corporate Officer/Principal | - | 11-06 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Weiguang Guo
BRD | Director/Board Member | 68 | - |
Stéphane Le Roux
CEO | Chief Executive Officer | 63 | 05-09-27 |
Joseph Brigneaud
BRD | Director/Board Member | 46 | 17-10-12 |
Spineway designs, produces, and sells spinal column implants and surgical instruments. The group offers spinal systems, cervical and lumbar cages, cervical plates, bone substitutes, etc.
Net sales are distributed geographically as follows: France (27.8%), Europe (21.4%), Latin America (29.8%), Asia (16.1%) and the Middle East and Africa (4.9%).
Calendar
2024-07-16
- Q2 2024 Sales and Revenue Release
| 1st Jan change | Capi. | |
|---|---|---|
| -5.50% | 181B | |
| -5.79% | 99.52B | |
| -6.59% | 65.82B | |
| -8.38% | 45.21B | |
| +8.42% | 43.85B | |
| +10.10% | 42.17B | |
| +10.97% | 28.75B | |
| +18.89% | 25.39B | |
| -8.39% | 23.5B |
